Millennium Pharmacon International
PT Millennium Pharmacon International Tbk engages in the distribution of prescription and non-prescription medicines and medical devices in Indonesia. The company was formerly known as PT NVPD Soedarpo Corporation Tbk and changed its name to PT Millennium Pharmacon International Tbk in February 1990. The company was founded in 1952 and is headquartered in Jakarta Selatan, Indonesia. PT Millennium… Read more
Millennium Pharmacon International (SDPC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.063x
Based on the latest financial reports, Millennium Pharmacon International (SDPC) has a cash flow conversion efficiency ratio of -0.063x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp-18.67 Billion) by net assets (Rp296.69 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Millennium Pharmacon International - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how Millennium Pharmacon International's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Millennium Pharmacon International Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Millennium Pharmacon International ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
LIFECARE AS NOK 040
F:LFC
|
N/A |
|
Cult Food Science Corp
OTCQB:CULTF
|
-0.202x |
|
Spindletop O&G
PINK:SPND
|
0.004x |
|
J.B.HUNT TRANSP
MU:JB1
|
0.085x |
|
Nevis Brands Inc.
OTCQB:NEVIF
|
0.026x |
|
Hypebeast Limited
PINK:HYPPF
|
-0.017x |
|
Mojo Organics Inc.
OTCQB:MOJO
|
0.423x |
|
Global Clean Energy Holdings
OTCQB:GCEH
|
-4.932x |
Annual Cash Flow Conversion Efficiency for Millennium Pharmacon International (2004–2024)
The table below shows the annual cash flow conversion efficiency of Millennium Pharmacon International from 2004 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp282.50 Billion | Rp-125.45 Billion | -0.444x | -34.56% |
| 2023-12-31 | Rp277.71 Billion | Rp-91.65 Billion | -0.330x | -308.43% |
| 2022-12-31 | Rp258.91 Billion | Rp41.00 Billion | 0.158x | +306.44% |
| 2021-12-31 | Rp236.98 Billion | Rp-18.18 Billion | -0.077x | -124.52% |
| 2020-12-31 | Rp229.20 Billion | Rp71.69 Billion | 0.313x | +391.54% |
| 2019-12-31 | Rp235.44 Billion | Rp-25.26 Billion | -0.107x | -627.27% |
| 2018-12-31 | Rp232.11 Billion | Rp4.72 Billion | 0.020x | -2.94% |
| 2017-12-31 | Rp212.61 Billion | Rp4.46 Billion | 0.021x | +111.13% |
| 2016-12-31 | Rp143.28 Billion | Rp-26.99 Billion | -0.188x | +63.20% |
| 2015-12-31 | Rp134.31 Billion | Rp-68.74 Billion | -0.512x | -1218.86% |
| 2014-12-31 | Rp121.79 Billion | Rp-4.73 Billion | -0.039x | +91.69% |
| 2013-12-31 | Rp114.87 Billion | Rp-53.67 Billion | -0.467x | -2326.94% |
| 2012-12-31 | Rp104.62 Billion | Rp2.19 Billion | 0.021x | +118.58% |
| 2011-12-31 | Rp94.78 Billion | Rp-10.70 Billion | -0.113x | -273.40% |
| 2007-12-31 | Rp70.24 Billion | Rp4.57 Billion | 0.065x | +391.77% |
| 2006-12-31 | Rp60.63 Billion | Rp802.62 Million | 0.013x | -78.04% |
| 2004-12-31 | Rp45.18 Billion | Rp2.72 Billion | 0.060x | -- |